These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis. Bilezikian JP; Rubin MR Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002 [TBL] [Abstract][Full Text] [Related]
4. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Garcés C; García LE Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150 [TBL] [Abstract][Full Text] [Related]
5. The potential of parathyroid hormone as a therapy for osteoporosis. Rubin MR; Bilezikian JP Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255 [TBL] [Abstract][Full Text] [Related]
6. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Brixen KT; Christensen PM; Ejersted C; Langdahl BL Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497 [TBL] [Abstract][Full Text] [Related]
8. The use of parathyroid hormone in the treatment of osteoporosis. Girotra M; Rubin MR; Bilezikian JP Rev Endocr Metab Disord; 2006 Jun; 7(1-2):113-21. PubMed ID: 17043762 [TBL] [Abstract][Full Text] [Related]
9. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis. Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908 [TBL] [Abstract][Full Text] [Related]
12. Combination anabolic and antiresorptive therapy for osteoporosis. Cusano NE; Bilezikian JP Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of osteoporosis with parathyroid hormone]. Syversen U; Halse JI Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056 [TBL] [Abstract][Full Text] [Related]
14. [Parathyroid hormone for osteroporsis: why and who to treat?]. Ferrari S; Rizzoli R Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450 [TBL] [Abstract][Full Text] [Related]
15. Treatment of osteoporosis with parathyroid hormone and teriparatide. Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903 [TBL] [Abstract][Full Text] [Related]
18. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis]. Wada S; Fukawa T; Kamiya S Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665 [TBL] [Abstract][Full Text] [Related]
19. The role of parathyroid hormone in the management of osteoporosis. Rosen CJ Horm Res; 2005; 64 Suppl 2():81-5. PubMed ID: 16286779 [TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone update. Hamann KL; Lane NE Rheum Dis Clin North Am; 2006 Nov; 32(4):703-19. PubMed ID: 17288973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]